Published on 17 Apr 2023 on Simply Wall St. via Yahoo Finance
Little Excitement Around Precision BioSciences, Inc.'s (NASDAQ:DTIL) Revenues
With a price-to-sales (or "P/S") ratio of 3.8x Precision BioSciences, Inc. (NASDAQ:DTIL) may be sending very bullish signals at the moment, given that almost half of all the Biotechs companies in the United States have P/S ratios greater than 11.5x and even P/S higher than 50x are not unusual. Nonetheless, we'd need to dig a little deeper to determine if there is a rational basis for the highly reduced P/S.
View our latest analysis for Precision BioSciences
